P. Morinière

753 total citations
33 papers, 496 citations indexed

About

P. Morinière is a scholar working on Nephrology, Nutrition and Dietetics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, P. Morinière has authored 33 papers receiving a total of 496 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Nephrology, 12 papers in Nutrition and Dietetics and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in P. Morinière's work include Parathyroid Disorders and Treatments (16 papers), Magnesium in Health and Disease (10 papers) and Aluminum toxicity and tolerance in plants and animals (6 papers). P. Morinière is often cited by papers focused on Parathyroid Disorders and Treatments (16 papers), Magnesium in Health and Disease (10 papers) and Aluminum toxicity and tolerance in plants and animals (6 papers). P. Morinière collaborates with scholars based in France, Switzerland and United States. P. Morinière's co-authors include A. Fournier, P. F. Westeel, A. Mariè, Jean‐Michel Achard, B Boudailliez, J. L. Sébert, Martine Cohen‐Solal, Jean‐Daniel Lalau, A. Fournier and N. El Esper and has published in prestigious journals such as Intensive Care Medicine, Bone and Nephrology Dialysis Transplantation.

In The Last Decade

P. Morinière

33 papers receiving 468 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. Morinière France 12 320 160 117 81 77 33 496
Robert Dunlay United States 10 264 0.8× 77 0.5× 75 0.6× 65 0.8× 140 1.8× 12 480
H. Erik Meema Canada 12 269 0.8× 130 0.8× 118 1.0× 65 0.8× 70 0.9× 18 539
Carolina Lara Neves Brazil 10 304 0.9× 96 0.6× 69 0.6× 95 1.2× 78 1.0× 25 417
M. Moustafa Switzerland 3 408 1.3× 161 1.0× 84 0.7× 131 1.6× 125 1.6× 4 461
Hans Rickers Denmark 13 131 0.4× 92 0.6× 122 1.0× 135 1.7× 48 0.6× 29 603
Gunhild A. Isaksen Norway 9 443 1.4× 80 0.5× 172 1.5× 145 1.8× 44 0.6× 11 590
H Renaud France 9 155 0.5× 81 0.5× 36 0.3× 47 0.6× 73 0.9× 28 314
Takao Tsuchida Japan 11 199 0.6× 97 0.6× 102 0.9× 63 0.8× 116 1.5× 28 398
J. B. Puschett United States 8 178 0.6× 37 0.2× 131 1.1× 74 0.9× 39 0.5× 12 417
Gérard Maruani France 13 284 0.9× 122 0.8× 87 0.7× 172 2.1× 140 1.8× 24 637

Countries citing papers authored by P. Morinière

Since Specialization
Citations

This map shows the geographic impact of P. Morinière's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Morinière with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Morinière more than expected).

Fields of papers citing papers by P. Morinière

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Morinière. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Morinière. The network helps show where P. Morinière may publish in the future.

Co-authorship network of co-authors of P. Morinière

This figure shows the co-authorship network connecting the top 25 collaborators of P. Morinière. A scholar is included among the top collaborators of P. Morinière based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Morinière. P. Morinière is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hardy, Peter, P. Morinière, Bruno Tribout, et al.. (2000). Liver granulomatosis is not an exceptional cause of hypercalcemia with hypoparathyroidism in dialysis patients.. PubMed. 12(6). 398–403. 7 indexed citations
2.
Hardy, Peter, A. Séchet, C Hottelart, et al.. (1998). Inhibition of Gastric Secretion by Omeprazole and Efficiency of Calcium Carbonate on the Control of Hyperphosphatemia in Patients on Chronic Hemodialysis. Artificial Organs. 22(7). 569–573. 44 indexed citations
3.
Séchet, A., Peter Hardy, C Hottelart, et al.. (1998). Role of Calcium Carbonate Administration Timing in Relation to Food Intake on Its Efficiency in Controlling Hyperphosphatemia in Patients on Maintenance Dialysis. Artificial Organs. 22(7). 564–568. 11 indexed citations
4.
Hottelart, C, et al.. (1998). Heparin‐Induced Hyperkalemia in Chronic Hemodialysis Patients: Comparison of Low Molecular Weight and Unfractionated Heparin. Artificial Organs. 22(7). 614–617. 30 indexed citations
5.
Fournier, A., P. Morinière, Roxana Oprisiu, et al.. (1995). 1-Alpha-Hydroxyvitamin D<sub>3 </sub>Derivatives in the Treatment of Renal Bone Diseases: Justification and Optimal Modalities of Administration. ˜The œNephron journals/Nephron journals. 71(3). 254–283. 28 indexed citations
6.
Esper, I. El, et al.. (1993). Long-Term (6 Months) Cross-Over Comparison of Calcium Acetate with Calcium Carbonate as Phosphate Binder. ˜The œNephron journals/Nephron journals. 63(3). 258–262. 24 indexed citations
7.
Morinière, P., et al.. (1992). [Spontaneously regressive hematoma of the liver after external heart massage].. PubMed. 21(27). 1294–5. 1 indexed citations
8.
Morinière, P., B Boudailliez, N. El Esper, et al.. (1992). Control of Predialytic Hyperphosphatemia by Oral Calcium Acetate and Calcium Carbonate. ˜The œNephron journals/Nephron journals. 60(1). 6–11. 25 indexed citations
9.
Morinière, P., A. Mariè, N. El Esper, et al.. (1991). Destructive Spondyloarthropathy with β<sub>2</sub>-Microglobulin Amyloid Deposits in a Uremic Patient before Chronic Hemodialysis. ˜The œNephron journals/Nephron journals. 59(4). 654–657. 32 indexed citations
10.
Mariè, A., B Boudailliez, P. Morinière, et al.. (1990). [Prevalence of histological types of bone disease in a hemodialysis center limiting the oral intake of aluminum hydroxide].. PubMed. 11(2). 83–90. 2 indexed citations
11.
Morinière, P., Martine Cohen‐Solal, B Boudailliez, et al.. (1989). Disappearance of Aluminic Bone Disease in a Long Term Asymptomatic Dialysis Population Restricting Al(OH)<sub>3</sub> Intake: Emergence of an Idiopathic Adynamic Bone Disease Not Related to Aluminum. ˜The œNephron journals/Nephron journals. 53(2). 93–101. 67 indexed citations
12.
Morinière, P., et al.. (1989). Low-Molecular-Weight Heparin Fraxiparin® in Chronic Hemodialysis. Blood Purification. 7(6). 301–308. 8 indexed citations
13.
Morinière, P., et al.. (1989). Long-term efficacy and safety of oral calcium as compared to A1(OH)3 as phosphate binders.. PubMed. 27. S133–5. 1 indexed citations
14.
15.
Sébert, J. L., A. Fournier, P. Morinière, et al.. (1986). Comparative Evaluation of Bone Aluminum Content and Bone Histology in Patients on Chronic Hemodialysis and Hemofiltration. ˜The œNephron journals/Nephron journals. 42(1). 34–40. 5 indexed citations
16.
Morinière, P., A. Fournier, M A Herve, et al.. (1985). Comparison of 1α-OH-Vitamin D<sub>3</sub> and High Doses of Calcium Carbonate for the Control of Hyperparathyroidism and Hyperaluminemia in Patients on Maintenance Dialysis. ˜The œNephron journals/Nephron journals. 39(4). 309–315. 17 indexed citations
17.
Demontis, R, et al.. (1985). 1 alpha OH vitamin D3 increases plasma aluminium in haemodialysed patients taking Al (OH)3.. PubMed. 21. 390–4. 1 indexed citations
18.
Morinière, P., et al.. (1985). The desferrioxamine test predicts bone aluminium burden induced by A1(OH)3 in uraemic patients but not mild histological osteomalacia.. PubMed. 21. 371–6. 3 indexed citations
19.
Fournier, A., et al.. (1984). Renal Osteodystrophy: Pathophysiology and Treatment. Hormone Research. 20(1). 44–58. 4 indexed citations
20.
Kuntz, D, et al.. (1983). Advantage of Hand Bone Calcium Content Measurement by Local Neutron Activation Analysis for Following Up Hemodialysis Patients. ˜The œNephron journals/Nephron journals. 34(4). 228–233. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Robert Dunlay Breakdown of academic impact, for papers by H. Erik Meema Breakdown of academic impact, for papers by Carolina Lara Neves Breakdown of academic impact, for papers by M. Moustafa Breakdown of academic impact, for papers by Hans Rickers Breakdown of academic impact, for papers by Gunhild A. Isaksen Breakdown of academic impact, for papers by H Renaud Breakdown of academic impact, for papers by Takao Tsuchida Breakdown of academic impact, for papers by J. B. Puschett Breakdown of academic impact, for papers by Gérard Maruani
Rankless by CCL
2026